Abstract
The OpenProt proteogenomic resource (https://www.openprot.org/) provides users with a complete and freely accessible set of non-canonical or alternative open reading frames (AltORFs) within the transcriptome of various species, as well as functional annotations of the corresponding protein sequences not found in standard databases. Enhancements in this update are largely the result of user feedback and include the prediction of structure, subcellular localization, and intrinsic disorder, using cutting-edge algorithms based on machine learning techniques. The mass spectrometry pipeline now integrates a machine learning-based peptide rescoring method to improve peptide identification. We continue to help users explore this cryptic proteome by providing OpenCustomDB, a tool that enables users to build their own customized protein databases, and OpenVar, a genomic annotator including genetic variants within AltORFs and protein sequences. A new interface improves the visualization of all functional annotations, including a spectral viewer and the prediction of multicoding genes. All data on OpenProt are freely available and downloadable. Overall, OpenProt continues to establish itself as an important resource for the exploration and study of new proteins.
Graphical Abstract
Introduction
Mass spectrometry (MS)-based proteomics, ribosome profiling (or ribo-seq), and evolutionary analyses concur toward the existence of proteins translated from noncanonical or alternative open reading frames (ORFs) (1,2). Alternative ORFs (or AltORFs) are ORFs that are not currently annotated in conventional databases, including NCBI RefSeq and Ensembl; they are present within UTRs or overlap the reference ORF in a different reading frame of mRNAs, or within RNAs annotated as non-coding (ncRNA). When present in an mRNA, AltORFs are generally smaller than the annotated reference ORF (RefORF) since RefORFs are typically the longest ORF in the mRNA. AltORFs includes a large fraction of small ORFs or short ORFs (Figure 1A). However, in contrast to small ORFs or short ORFs which are usually limited to ORFs below 100 codons, there is no maximum size restriction for AltORFs. To maintain tractable downstream analyses it is necessary to limit the size of the total AltORFeome, therefore only AltORFs larger than 29 codons are considered. Investigations into this largely unexplored orfeome and proteome require specific resources to provide deeper annotations essential for proteogenomics strategies.
OpenProt annotations (2) stem from challenging long-standing dogmas, including a single protein-coding ORF -typically the longest- in mRNAs, the 100-codon threshold for a functional ORF, the absence of protein-coding ORFs in ncRNAs, and the systematic annotation of pseudogenes-derived RNAs as ncRNAs. A relaxation of these conventional rules is essential to create customized databases for discovering alternative proteins (AltProts) and initiating their functional characterization. From all possible ORFs larger than 29 codons within the transcriptome of RefSeq and Ensembl and without a priori regarding the RNA biotype, OpenProt annotates three types of proteins (Figure 1B): (i) RefProts, also known as reference proteins, comprise well-identified proteins annotated in NCBI RefSeq, Ensembl, and/or UniProt. (ii) Novel isoforms (accession II_) represent unannotated proteins that exhibit a substantial sequence similarity to a RefProt encoded in the same gene. (iii) Finally, AltProts (accession IP_) denote unannotated proteins that lack significant identity with any RefProt associated with the same gene. Using these new annotations, OpenProt reanalyses ribo-seq and MS-based proteomics studies to provide evidence of expression and display protein domains and conservation (Figure 1B).
Since its previous release in 2021 (v1.6) (3), 4587 AltProts and 9163 novel isoforms have changed to RefProts following their annotation in UniProt, NCBI RefSeq and/or Ensembl, illustrating both the impact of the alternative and small ORFs community and the high-standard OpenProt annotations (Table 1). OpenProt users have provided constructive feedback based on their experience using the site, and their comments have been instrumental in several new developments in this update. Here, we present OpenProt v2.0 which incorporates transcript expression, structure predictions, intrinsically disordered regions, and short linear motifs. Also implemented are a new MS data analysis pipeline that includes machine learning-based peptide-spectrum match rescoring to improve identification rates, and a frequently requested mass spectrum viewer to explore MS evidence of each detected protein. OpenProt v2.0 also makes available OpenVar, a genomic variant annotator and effect predictor for multiple ORFs on single transcripts, and OpenCustomDB, a tool to generate RNAseq-derived personalized databases accounting for alternative ORFs and their variants (Figure 1C). All ORFs prediction analyses were recomputed with the March 2023 RefSeq (217) and Ensembl (106) annotations, and all prediction and expression analyses were computed with the latest version of the softwares. Overall, OpenProt now integrates both functional annotations and specific tools to explore AltORFs and AltProts. Finally, the platform features a new web interface to facilitate the exploration of the data.
Table 1.
Species | AltProt v1.6 to RefProt v2.0 (#) | Novel isoform v1.6 to RefProt v2.0 (#) | Total changes (#) |
---|---|---|---|
H. sapiens | 2441 | 5316 | 7757 |
P. troglodytes | 106 | 440 | 546 |
M. musculus | 1326 | 1898 | 3224 |
R. norvegicus | 218 | 430 | 648 |
B. taurus | 1 | 18 | 19 |
O. aries | 33 | 639 | 672 |
D. rerio | 1 | 47 | 48 |
D. melanogaster | 453 | 302 | 755 |
C. elegans | 8 | 73 | 81 |
S cerevisiae | 0 | 0 | 0 |
All 10 species | 4587 | 9163 | 13 750 |
Updates and new developments
Genome annotation, ORFs prediction and genome browser
OpenProt 2.0 is based on genome annotations from January 2023 for each species. Table 2 lists genome assemblies, annotation releases, and the number of predicted ORFs categorized as RefORF, novel isoforms, and AltORFs (Supplementary S1 and S2). Two additional species were added: Xenopus tropicalis and Arabidopsis thaliana. Data for all species can be downloaded as tsv, fasta or bed files. All ORF and protein predicted and annotated by OpenProt are displayed in a new genome browser which includes tracks for transcripts and for all predicted proteins coded by the corresponding transcripts.
Table 2.
Annotations | ORFeome (Ensembl & NCBI RefSeq) | ||||||
---|---|---|---|---|---|---|---|
Species | Genome assembly | Ensembl | NCBI RefSeq | RefProt | AltProt | Novel isoforms | Total |
H. sapiens | GRCh38.p13 | GRCh38.106 | GRCh38.p13 | 247352 | 595788 | 70786 | 913926 |
P. troglodytes | Pan_tro_3.0 | Pan_tro_3.0.106 | Pan_tro_3.0 | 140749 | 258489 | 16329 | 415567 |
R. norvegicus | mRatBN7.2 | mRatBN7.2.106 | mRatBN7.2 | 89015 | 328386 | 16499 | 433900 |
M. Musculus | GRCm39 | GRCm39.106 | GRCm39 | 125814 | 501899 | 47930 | 675643 |
B. taurus | ARS-UCD1.2 | ARS-UCD1.2.106 | ARS-UCD1.2 | 76027 | 206599 | 11419 | 294045 |
O. aries | Oar_v3.1 | Oar_v3.1.106 | Oar_v3.1 | 97620 | 284298 | 14367 | 396285 |
X. tropicalis | UCB_Xtro_10.0 | UCB_Xtro_10.0.107 | UCB_Xtro_10.0 | 72622 | 217436 | 8666 | 298724 |
D. rerio | GRCz11 | GRCz11.106 | GRCz11 | 83325 | 208073 | 11710 | 303108 |
D. melanogaster | Release 6 plus ISO1 MT | BDGP6.32.106 | BDGP6.32 | 42682 | 82406 | 1909 | 126997 |
C. elegans | WBcel235 | WBcel235.106 | WBcel235 | 29502 | 66719 | 2978 | 99199 |
S. cerevisiae | R64-1-1 | R64-1-1.106 | R64 | 4859 | 10268 | 1909 | 17036 |
A. thaliana | TAIR10 | TAIR10.54 | TAIR10 | 114859 | 119499 | 5031 | 239389 |
Additional functional annotations
To determine which predicted proteins annotated by OpenProt are likely functional components of cellular processes it is useful to curate an assortment of functional analyses on these sequences (Supplementary S1). Results from the analyses described below are made available on the OpenProt website for browsing and download.
Tissue-specific transcript expression
Since OpenProt's functional annotations are primarily transcriptome-based, users have requested the incorporation of transcript expression data. These data were obtained for all transcripts annotated in the Genotype-Tissue Expression (GTEx) portal, a resource reporting the landscape of gene expression in multiple human tissues (4) and are displayed as transcript per million.
Structure prediction
For a large number of novel isoforms and AltProts annotated in OpenProt, the ability to predict the structure from their amino acid sequence represents an important step in their functional characterization. AlphaFold2 preprocesses multiple sequence alignments and provides accurate predictions for proteins with sequence homologs (5). Among the factors that limit the accuracy of AlphaFold predictions, a minimum of 30 sequences in the multiple sequence alignments is important to generate confident structure predictions. This is a challenge for AltProts which have no significant homology to other proteins. For proteins with multiple sequence alignments with less than 30 sequences, OmegaFold was used (6). OmegaFold is a new protein structure prediction method that does not rely on multiple sequence alignments but on amino-acid sequence only. Both methods predict structures with a confidence measure called the predicted local distance difference test or pLDDT. A total of 96 800 human AltProts and 29 017 novel isoforms display a high (90 > pLDDT > 70) to very high (pLDDT > 90) confidence score (Supplementary S3, panel A). This reliable estimate of the degree of agreement between predicted and experimental structure for several thousand proteins suggests that these newly predicted proteins may adopt specific structures and perform specific biological functions. This observation is expected to stimulate further research into the molecular function of these proteins.
Intrinsically disordered regions
Proteins with intrinsically disordered regions (or IDRs) have important roles in many biological processes and diseases (7). The research community has often raised the possibility that AltProts may be unstructured and enriched in IDRs compared to RefProts. Indeed, a large fraction of AltProts have a pLDDT < 50 which could indicate a propensity to display IDRs (Supplementary S3, panel A). We used the flDPnn computational tool (8) to predict disorder and disorder function in all protein sequences. Typically, functionally relevant IDRs are defined as containing 30 consecutive residues or more (9). Since the shortest proteins in OpenProt are 29 amino acids long, we computed IDRs with a minimum of 29 disordered consecutive residues and found that 15.7% of RefProts, 22.09% of AltProts and 24.05% of novel isoforms contain at least one IDR (Supplementary S3, panel B).
Short linear motifs
Short linear motifs (SLiMs) are small functional motifs of three to about 20 amino acids with critical biological functions, usually located in IDRs (10). All proteins were analyzed with the Eukaryotic Linear Motif resource (11) and SLiMs with at least one amino acid predicted as ordered were filtered out.
Subcellular localization prediction
DeepLoc 2.0 was used to predict the subcellular localization from the sequences of all proteins (12).
Mass spectrometry data analysis
An important goal of OpenProt is the discovery of novel proteins, i.e. to gather evidence of expression of predicted proteins both at the translational and protein levels by reanalyzing large-scale Ribo-seq and MS-based proteomics data (Supplementary S4). For typical bottom-up proteomics, the size of protein sequence databases integrating RefProts, novel isoforms, and AltProts is an important challenge, as it introduces greater uncertainty between peptide-spectrum matches, ultimately leading to a decreased number of identified peptides. In this update, we introduced deep learning predictions with MS2Rescore (13) to improve the rescoring of peptide spectrum matches and increase peptide identification rates (Figure 2). Raw data extracted from publicly available datasets (Supplementary S4) were analyzed with 4 search engines (X!Tandem, MS-GF+, Comet and OMSSA) with the interface SearchGUI (version 4.2.8). Identifications were aggregated into a single identification set using PeptideShaker (version 2.2.23) as previously described (2). Peptide-spectrum matches were rescored using a combination of MS2PIP, a spectral intensity predictor (14), a high-performance liquid chromatography retention time predictor, DeepLC (15), and the postprocessing tool Percolator (16) within MS2Rescore (13) as previously described (17) (Figure 3). This method improves the sensitivity of peptide spectrum matching and allows the identification of a larger number of peptides. Using the same MS datasets from the previous version of OpenProt 10047 alternative proteins that initially were only identified by one peptide now have two or more peptides detected. Peptide spectrum matches were selected by applying a FDR <0.01%, and peptides unicity from AltProts and novel isoforms was checked against Ensembl, RefSeq and UniProt.
OpenProt new tools
Two tools accessible both as a Python package and as a user-friendly web-based platform, OpenVar and OpenCustomDB, have been added and are accessible from the Home Page (Figure 3).
OpenVar is a new genomic variant annotator and effect predictor for multiple ORFs on single transcripts, including overlapping ORFs, that extends genomic variant analysis to include non-canonical ORFs (18). OpenVar predicts the effect of genomic variants in all ORFs annotated in OpenProt. Standard variant calling files are used as input.
OpenCustomDB utilizes sample-specific RNA-seq data to detect genetic variants within all ORFs annotated in OpenProt and builds customized protein sequence databases (19). With default parameters, the custom database is configured to accommodate a maximum of 100 000 proteins, with the number of transcripts restricted accordingly. Users can provide a transcript inclusion or exclusion list rather than rely solely on the expression level threshold. Standard variant calling files and transcript expression files are used as input.
Database development
All data were generated using in-house Python (version 3.6.9) scripts and stored in a SQLite database (version 3.38).
Web server
The search query can include a gene name, a protein, or a transcript accession from UniProt, RefSeq NCBI, Ensembl, or OpenProt. When searching for a gene name, the search results page displays all proteins associated with this gene, including the proteins already annotated in UniProt, RefSeq, and Ensembl, as well as AltProts and novel isoforms predicted by OpenProt. Proteins are sorted according to experimental evidence and transcripts that encode more than one protein for which a certain level of evidence is available are marked by an icon to indicate their likely multi-coding status (Figure 4A). The level of evidence required for each protein is at least 2 unique peptides detected in the MS dataset or 1 peptide plus one detection in a Ribo-seq dataset. From the search results page a details page displaying the functional annotations for each protein can be accessed. Figure 4B shows the summary tab of the details page for protein A0A823ADP9, previously annotated by OpenProt with the accession ID IP_243680 and now annotated by UniProtKB. Thus, protein A0A823ADP9 is a second reference protein coded by the FUS gene.
Mass spectrum viewer
Typical MS/MS proteomics analyses produce both spectra of fragmented ions, and their corresponding matched peptides. Previously, OpenProt displayed matched peptides only, but the new version now includes a spectrum viewer that allows the visualization and download of MS2 spectra in the browser (Figure 4C). This direct access to analytical results provides the user with more detailed information and enables a more accurate assessment of the quality of the evidence.
Links to other repositories
Some repositories, including uORFdb (20), sORFs (21), SmProt (22) and nuORFdb (23) list short ORFs that are predicted or with evidence of ribo-seq. For AltORFs shared between OpenProt and these repositories, the repository-specific accession identifier and link, when available, are provided on each protein details page. OpenProt shares 19 651, 871, 33 552 and 21 337 human AltORFs with uORFdb, sORFs, SmProt and nuRFFdb.
Conclusion
To the best of our knowledge, no other resource provides functional annotation of RNAs by allowing the presence of multiple ORFs on the same RNA independently of its biotype, thus facilitating functional exploration of proteins encoded in non-canonical coding sequences and recognizing the multicoding (polycistronic) nature of eukaryotic RNAs. Over the last three years, we have carried out significant development of OpenProt. On the functional annotations side, we have added predictions for the structure, subcellular localization, intrinsic disorder, and the presence of short linear motifs. Although most of the additional information provided in this update concerns human annotations, this information will also be available in the short term for the other species available in OpenProt. We have also incorporated deep learning-based predictions of peptide properties in the MS analysis pipeline to improve peptide identifications and added a spectral viewer. Two new tools have been made available to allow users to build their own customized protein sequence databases from RNAseq data incorporating RefProts, AltProts and novel isoforms, including genetic variants. With the increasing complexity of the resource, we also released a new website to facilitate access to the different data and tools.
The prediction of protein-protein complexes using molecular surface interaction fingerprinting (24) is one of the next planned new developments for OpenProt. All the resources available on OpenProt should help users to detect and investigate the function of new proteins, thereby improving knowledge of the molecular function of eukaryotic genes.
Supplementary Material
Acknowledgements
We thank Darel Hunting and Frédéric Comtois for helpful discussions. F.M.B., M.S., M.A.B. and X.R. are members of the Fonds de Recherche du Québec Santé (FRQS)-supported Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke. Computations were made on the supercomputers mp2, Béluga, Narval, Graham, Cedar, managed by Calcul Québec and the Digital Research Alliance of Canada. The operation of these supercomputers is funded by the Canada Foundation for Innovation (CFI), Ministère de l’Économie et de l’Innovation du Québec (MEI) and le Fonds de Recherche du Québec (FRQ).
Contributor Information
Sébastien Leblanc, Department of Biochemistry and Functional Genomics, Université de Sherbrooke, 3201 Jean Mignault, Sherbrooke, QC J1E 4K8, Canada.
Feriel Yala, Department of Biochemistry and Functional Genomics, Université de Sherbrooke, 3201 Jean Mignault, Sherbrooke, QC J1E 4K8, Canada.
Nicolas Provencher, Department of Biochemistry and Functional Genomics, Université de Sherbrooke, 3201 Jean Mignault, Sherbrooke, QC J1E 4K8, Canada.
Jean-François Lucier, Center for Computational Science, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada; Department of Biology, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada.
Maxime Levesque, Center for Computational Science, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada.
Xavier Lapointe, Department of Pediatrics, Medical Genetics Service, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
Jean-Francois Jacques, Department of Biochemistry and Functional Genomics, Université de Sherbrooke, 3201 Jean Mignault, Sherbrooke, QC J1E 4K8, Canada.
Isabelle Fournier, INSERM U1192, Laboratoire Protéomique, Réponse Inflammatoire & Spectrométrie de Masse (PRISM), Université de Lille, F-59000 Lille, France.
Michel Salzet, INSERM U1192, Laboratoire Protéomique, Réponse Inflammatoire & Spectrométrie de Masse (PRISM), Université de Lille, F-59000 Lille, France.
Aïda Ouangraoua, Informatics Department, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada.
Michelle S Scott, Department of Biochemistry and Functional Genomics, Université de Sherbrooke, 3201 Jean Mignault, Sherbrooke, QC J1E 4K8, Canada; Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CRCHUS), Sherbrooke, QC J1H 5N4, Canada.
François-Michel Boisvert, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CRCHUS), Sherbrooke, QC J1H 5N4, Canada; Department of Immunology and Cellular Biology, Université de Sherbrooke, Sherbrooke, QC J1E 4K8, Canada.
Marie A Brunet, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CRCHUS), Sherbrooke, QC J1H 5N4, Canada; Department of Pediatrics, Medical Genetics Service, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
Xavier Roucou, Department of Biochemistry and Functional Genomics, Université de Sherbrooke, 3201 Jean Mignault, Sherbrooke, QC J1E 4K8, Canada; Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CRCHUS), Sherbrooke, QC J1H 5N4, Canada.
Data availability
OpenProt 2.0 is freely available without registration or login at https://www.openprot.org/.
Supplementary data
Supplementary Data are available at NAR Online.
Funding
Canada Research Chair in Functional Proteomics and Discovery of Novel Proteins and Advanced research computing resources from Digital Research Alliance of Canada (to X.R.); M.A.B. is a recipient of a Junior 1 research scholarship from the Fonds de Recherche du Québec – Santé. Funding for open access charge: Canada Research Chairs.
Conflict of interest statement. None declared.
References
- 1. Mudge J.M., Ruiz-Orera J., Prensner J.R., Brunet M.A., Calvet F., Jungreis I., Gonzalez J.M., Magrane M., Martinez T.F., Schulz J.F.et al.. Standardized annotation of translated open reading frames. Nat. Biotechnol. 2022; 40:994–999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Brunet M.A., Brunelle M., Lucier J.F., Delcourt V., Levesque M., Grenier F., Samandi S., Leblanc S., Aguilar J.D., Dufour P.et al.. OpenProt: a more comprehensive guide to explore eukaryotic coding potential and proteomes. Nucleic Acids Res. 2019; 47:D403–D410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Brunet M.A., Lucier J.F., Levesque M., Leblanc S., Jacques J.F., Al-Saedi H.R.H., Guilloy N., Grenier F., Avino M., Fournier I.et al.. OpenProt 2021: deeper functional annotation of the coding potential of eukaryotic genomes. Nucleic Acids Res. 2021; 49:D380–D388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Consortium G.T.E. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020; 369:1318–1330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Jumper J., Evans R., Pritzel A., Green T., Figurnov M., Ronneberger O., Tunyasuvunakool K., Bates R., Žídek A., Potapenko A.et al.. Highly accurate protein structure prediction with AlphaFold. Nature. 2021; 596:583–589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Wu R., Ding F., Wang R., Shen R., Zhang X., Luo S., Su C., Wu Z., Xie Q., Berger B.et al.. High-resolution de novo structure prediction from primary sequence. 2022; bioRxiv doi:22 July 2022, pre-print: not peer-reviewed 10.1101/2022.07.21.500999. [DOI]
- 7. Babu M.M., van der Lee R., de Groot N.S., Gsponer J.. Intrinsically disordered proteins: regulation and disease. Curr. Opin. Struct. Biol. 2011; 21:432–440. [DOI] [PubMed] [Google Scholar]
- 8. Hu G., Katuwawala A., Wang K., Wu Z., Ghadermarzi S., Gao J., Kurgan L.. flDPnn: accurate intrinsic disorder prediction with putative propensities of disorder functions. Nat. Comm. 2021; 12:4438. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Peng Z., Yan J., Fan X., Mizianty M.J., Xue B., Wang K., Hu G., Uversky V.N., Kurgan L.. Exceptionally abundant exceptions: comprehensive characterization of intrinsic disorder in all domains of life. Cell. Mol. Life Sci. 2015; 72:137–151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Van Roey K., Uyar B., Weatheritt R.J., Dinkel H., Seiler M., Budd A., Gibson T.J., Davey N.E.. Short linear motifs: ubiquitous and functionally diverse protein interaction modules directing cell regulation. Chem. Rev. 2014; 114:6733–6778. [DOI] [PubMed] [Google Scholar]
- 11. Kumar M., Michael S., Alvarado-Valverde J., Mészáros B., Sámano-Sánchez H., Zeke A., Dobson L., Lazar T., Örd M., Nagpal A.et al.. The Eukaryotic Linear Motif resource: 2022 release. Nucleic Acids Res. 2022; 50:D497–D508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Thumuluri V., Almagro Armenteros J.J., Johansen A.R., Nielsen H., Winther O.. DeepLoc 2.0: multi-label subcellular localization prediction using protein language models. Nucleic Acids Res. 2022; 50:W228–W234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Declercq A., Bouwmeester R., Hirschler A., Carapito C., Degroeve S., Martens L., Gabriels R.. MS2Rescore: data-driven rescoring dramatically boosts immunopeptide identification rates. Mol. Cell. Proteomics. 2022; 21:100266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Declercq A., Bouwmeester R., Chiva C., Sabidó E., Hirschler A., Carapito C., Martens L., Degroeve S., Gabriels R.. Updated MS²PIP web server supports cutting-edge proteomics applications. Nucleic Acids Res. 2023; 51:W338–W342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Bouwmeester R., Gabriels R., Hulstaert N., Martens L., Degroeve S.. DeepLC can predict retention times for peptides that carry as-yet unseen modifications. Nat. Methods. 2021; 18:1363–1369. [DOI] [PubMed] [Google Scholar]
- 16. The M., MacCoss M.J., Noble W.S., Käll L.. Fast and accurate protein false discovery rates on large-scale proteomics data sets with percolator 3.0. J. Am. Soc. Mass. Spectrom. 2016; 27:1719–1727. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Verbruggen S., Gessulat S., Gabriels R., Matsaroki A., Van de Voorde H., Kuster B., Degroeve S., Martens L., Van Criekinge W., Wilhelm M.et al.. Spectral prediction features as a solution for the search space size problem in proteogenomics. Mol. Cell. Proteomics. 2021; 20:100076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Brunet M.A., Leblanc S., Roucou X.. OpenVar: functional annotation of variants in non-canonical open reading frames. Cell Biosci. 2022; 12:130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Guilloy N., Brunet M.A., Leblanc S., Jacques J.F., Hardy M.P., Ehx G., Lanoix J., Thibault P., Perreault C., Roucou X.. OpenCustomDB: integration of unannotated open reading frames and genetic variants to generate more comprehensive customized protein databases. J. Proteome Res. 2023; 22:1492–1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Manske F., Ogoniak L., Jürgens L., Grundmann N., Makalowski W., Wethmar K.. The new uORFdb: integrating literature, sequence, and variation data in a central hub for uORF research. Nucleic Acids Res. 2023; 51:D328–D336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Olexiouk V., Van Criekinge W., Menschaert G.. An update on sORFs.Org: a repository of small ORFs identified by ribosome profiling. Nucleic Acids Res. 2028; 46:D497–D502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Li Y., Zhou H., Chen X., Zheng Y., Kang Q., Hao D., Zhang L., Song T., Luo H., Hao Y.et al.. SmProt: A Reliable Repository with Comprehensive Annotation of Small Proteins Identified from Ribosome Profiling. Genomics Proteomics Bioinformatics. 2021; 19:602–610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Ouspenskaia T., Law T., Clauser K.R., Klaeger S., Sarkizova S., Aguet F., Li B., Christian E., Knisbacher B.A., Le P.M.. Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nat. Biotechnol. 2022; 40:209–217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Gainza P., Sverrisson F., Monti F., Rodolà E., Boscaini D., Bronstein M.M., Correia B.E.. Deciphering interaction fingerprints from protein molecular surfaces using geometric deep learning. Nat. Methods. 2020; 17:184–192. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
OpenProt 2.0 is freely available without registration or login at https://www.openprot.org/.